Using artificial intelligence to read CT scans of kidney tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether artificial intelligence (AI) can help doctors tell kidney tumors apart from non-cancerous growths using a regular CT scan without contrast dye. If the AI works well, it could help doctors make better decisions without the need for extra procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a CT scan of your belly (abdomen) at a participating hospital.
- You have not received any treatment for your kidney condition before this study.
- Your doctor is following a standard plan for your kidney finding, which may include watching it over time, taking a tissue sample (biopsy), or surgery.
- If your kidney lesion looks like cancer, it must be confirmed by a tissue sample; if it looks benign, it can be confirmed by a biopsy or by follow-up scans.
- Your CT scan images need to be clear enough for doctors to review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This study uses a computer program (deep learning) to look at your kidney CT scan and tell if your cancer is more advanced (stage T3) or earlier (stage T1-T2). The goal is to help doctors plan the best treatment for you.
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
This study tests whether a computer program can find cancer signs in CT scans that were done for other reasons (like check-ups) without needing a separate special scan. If you've already been diagnosed with breast, liver, kidney, or bladder cancer and had a CT scan before treatment, you might be able to join.
Hear when a new Renal Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.